HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 61861Erstellt: 27. Oktober 2026
Magnesiumhexafluorosilicat
MAGNESIUM HEXAFLUOROSILICATE · Caswell no. 532 · Einecs 241-022-2 · Magnesium fluorosili · MAGNESIUM FLUOSILICATE · MAGNESIUM SILICOFLUORIDE · Magnesiumhexafluorsilikat · MAGNESIUMHEXAFLUOSILICATE
https://huagongshe.com/de/chemical/61861
Identifikatoren & physikalische Daten
| CAS No. | 16949-65-8 |
|---|
| Summenformel | F6Si.Mg |
|---|
| Durchschnittliche Molmasse | 166,38 g/mol |
|---|
| Monoisotopische Masse | 165,95238755 g/mol |
|---|
| SMILES | F[Si-2](F)(F)(F)(F)F.[Mg+2] |
|---|
| InChIKey | INWUJAAIUAAHJA-UHFFFAOYSA-N |
|---|
| PubChem CID | 61861 |
|---|
| EC No. | 241-022-2 |
|---|
| DTXSID | DTXSID70884950 |
|---|
| Lokaler Name | Magnesiumhexafluorosilicat |
|---|
Chemische & physikalische Eigenschaften
| Polarare Oberfläche (TPSA) | 0 |
|---|
| H-Brücken-Donoren | 0 |
|---|
| H-Brücken-Akzeptoren | 7 |
|---|
| Frei drehbare Bindungen | 0 |
|---|
| Schwere Atome | 8 |
|---|
| Formalladung | 0 |
|---|
| Komplexität | 62,7 |
|---|
| Stoffklassen | Mineral Dusts -> Other Mineral Dusts |
|---|
| Kosmetika | AntiplaqueOral care |
|---|
| Physical Description | Magnesium fluorosilicate is a crystalline solid. Decomposes at 120 °C. Contact may cause slight irritation to skin, eyes, and mucous membranes. May be slightly toxic by ingestion. Used to make other chemicals.Dry Powder[CAMEO] White powder[Gelest MSDS] |
|---|
| Schmelzpunkt | 120°C |
|---|
| Siedepunkt | >120°C |
|---|
| Dichte | 1.788 |
|---|
| Dampfdruck | 0.001Pa at 25℃ |
|---|
| Aggregatzustand | Powder |
|---|
| Wichte | 1.788 |
|---|
| Löslichkeit | 498.4g/L at 18.3℃ |
|---|
| Kosmetik-Inhaltsstoffe Funktionen | ANTIPLAQUEORAL CARE |
|---|
| InChI | InChI=1S/F6Si.Mg.6H2O/c1-7(2,3,4,5)6/h6*1H2/q-2+2 |
|---|
| InChIKey | ZYDDCPHMRLLEEV-UHFFFAOYSA-N |
|---|
| SMILES | [Si-2](F)(F)(F)(F)(F)F.O.O.O.O.O.O.[Mg+2] |
|---|
| LogP (Verteilungskoeffizient) | 0 at 25℃ |
|---|
| CAS Datenbank | 16949-65-8(CAS DataBase Reference) |
|---|
| EPA chemische Informationen | Magnesium fluosilicate (16949-65-8) |
|---|
Sicherheit & Vorschriften
| GHS-Einstufung | DangerH301: Toxic if swallowed [Danger Acute toxicity, oral]P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]P261, P264, P264+P265, P270, P271, P280, P301+P316, P304+P340, P305+P354+P338, P317, P321, P330, P405, and P501 (click each P-code to see the statement) |
|---|
| Regulatorische Informationen | Chemical: Silicate(2-), hexafluoro-, magnesium (1:1)Silicate(2-), hexafluoro-, magnesium (1:1) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Silicate(2-), hexafluoro-, magnesium (1:1) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)REACH registered substance: Magnesium hexafluorosilicate (EC: 241-022-2)Magnesium hexafluorosilicate: Does not have an individual approval but may be used under an appropriate group standardMagnesium fluorosilicate: Does not have an individual approval but may be used under an appropriate group standard |
|---|
| Weitere Sicherheitsinformationen | IMAP assessments - Magnesium hexafluorosilicates: Human health tier II assessment |
|---|
| DOT-Kennzeichnung | Poison |
|---|
| Brandgefahren | Excerpt from ERG Guide 151 [Substances - Toxic (Non-Combustible)]:· Non-combustible, substance itself does not burn but may decompose upon heating to produce corrosive and/or toxic fumes. |
|---|
| Gesundheitsgefahren | Excerpt from ERG Guide 151 [Substances - Toxic (Non-Combustible)]:· Highly toxic, may be fatal if inhaled, ingested or absorbed through skin. |
|---|
| Gefahrenübersicht | Toxic by ingestionMay cause serious eye injury [Classifications by the EC] Not a skin irritant in rabbits (80% aqueous solution)Hematological and clinical chemistry changes, adverse dental effects, mineralization in bone tissue, interstitial nephritis, hyperkeratosis of the stomach, increased relative liver and kidney weights, and increased relative testes and adrenal weights in males observed in 4-week oral study of rats at 3,000 ppm dietary (approximately 300 mg/kg/day) |
|---|